PTD-DBM: The Peptide That Grows New Follicles
Every other hair treatment tries to save existing follicles. PTD-DBM does something fundamentally different — it grows entirely new ones. Here is the research behind the breakthrough.
In 2018, researchers at Yonsei University in Seoul published a paper in the Journal of Investigative Dermatology that changed the conversation about hair restoration. They had identified a protein called CXXC5 as a key negative regulator of the Wnt pathway in hair follicles — and found that blocking it led to de novo hair follicle formation.
De novo. Not reactivation of dormant follicles. Not extension of existing growth cycles. The formation of entirely new follicles in areas that previously had none.
The peptide they developed to block CXXC5 was PTD-DBM.
The CXXC5 Discovery
The Wnt/β-catenin pathway, which GHK-Cu also targets, is the master regulator of hair follicle development. In adult skin, this pathway is tonically suppressed to prevent uncontrolled proliferation. CXXC5 is one of the suppressors — it physically prevents the Wnt cascade from activating follicle-producing programs.
The Korean team discovered that CXXC5 levels are elevated in balding scalp regions. More critically, they showed that CXXC5 knockout mice developed extra hair follicles and maintained denser hair into old age.
The question became: can we block CXXC5 pharmacologically without systemic side effects?
How PTD-DBM Works
PTD-DBM is a cell-permeable peptide consisting of two domains: - PTD (Protein Transduction Domain): Allows the peptide to cross the cell membrane - DBM (Dvl-Binding Motif): Competes with CXXC5 for binding to Dishevelled (Dvl), a key Wnt pathway component
When CXXC5 cannot bind Dvl, the Wnt cascade is freed from inhibition. β-catenin accumulates and translocates to the nucleus, activating genes associated with follicle morphogenesis.
Animal Model Results
In the published study, topical application of PTD-DBM combined with valproic acid (another CXXC5/GSK3β inhibitor) produced: - ~80% recovery of hair follicles in a wound-healing model where follicle neogenesis is normally absent - Complete de novo follicle structures with all normal architectural features - Follicles that continued through normal cycling once formed
Where It Fits in a Protocol
PTD-DBM is classified as an advanced compound for good reason. The human data is limited. The animal results are extraordinary, but translating neogenesis from mouse skin to human scalp involves real biological differences.
Our recommendation: complete at least one 12-week cycle of the Foundation Routine (GHK-Cu + BPC-157) before adding PTD-DBM. This ensures the scalp environment — vasculature, inflammation, extracellular matrix — is prepared for new follicle formation.
PTD-DBM is the ceiling of what peptide science can currently offer for hair restoration. It is also the most exciting development in the field in decades.